NEWS and OPINIONS
Breaking new ground on an allogeneic immunotherapy
by Felix Myhill - RegMedNet Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer. Allogeneic cell therapies differ from autologous cell...
Study shows immune molecule may play key role in the progression of ALS
By Mayo Clinic's Discovery's Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The team also found...
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
By Gina Kolata - The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the...
Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow
By News Medical Life Sciences Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in...
Why the Time Is Now for Allogeneic Cell Therapies
By Andrew Schulman - Technology Networks Why do we need allogeneic therapies when autologous therapies have enjoyed such success? The lessons learned from the development and manufacture of autologous cell therapies are helping lay a solid groundwork for the high...
How an insurer abandoned a cancer patient in his most critical hour
By Carrie Cochran and Catie Beck - Scripps News and ProPublica Forrest VanPatten was diagnosed with an aggressive form of lymphoma, but his insurance company denied coverage for a clinically proven treatment. in July 2019. That same month, he turned 50 years old....
Why Does This Hybrid Monkey Glow Green?
By Meghan Bartels - Scientific American Scientists have just achieved a milestone in stem-cell biology after creating a monkey from two embryos. And proof of the achievement, perhaps unnervingly, showed up in the infant primate’s eerie green glow. Although research...
Stem cell research paves way toward regenerating skeletal muscle
by Sarah C.P. Williams, UCLA - Phys.org News Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA are one step closer to developing stem cell therapies to regenerate skeletal muscle in humans. Working in mice, the...
Sharing the Serendipity of Science: How Cell Developmental Biology Fits Into the Future of Medicine
by Tristan Epps - Penn Medicine News Ben Stanger, MD, PhD is a practicing Gastroenterologist at Penn Medicine. He is also the Hanna Wise Professor in Cancer Research and professor of Medicine and Cell and Developmental biology at the University of Pennsylvania....
‘Super Melanin’ Heals Skin Injuries From Sunburn, Chemical Burns
By Marla Paul - Northwestern Medicine Synthetic cream also protects skin from sun damage Imagine a skin cream that heals damage occurring throughout the day when your skin is exposed to sunlight or environmental toxins. That’s the potential of a synthetic, biomimetic...
Researchers identify new criteria to detect rapidly progressive dementia
Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient's first clinical visit. This scoring criteria may allow physicians to...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
By Reuters News Oct 31 (Reuters) - A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If the...